I'm confused. Is this good news or not? First, I thought MANF was being developerd primarily for Parkinson's disease and Alzheimer's. Second, per the FDA website: ..."because so few individuals are affected by any one rare disease or condition, a pharmaceutical company which develops an orphan drug may reasonably expect the drug to generate relatively small sales in comparison to the cost of developing the drug and consequently to incur a financial loss". Again, is this good or bad news?
A long time ago I had a friend who developed liver c and went down hill fast, he died within a year...young guy. During his testing and diagnosis it came to light that the eyes were one of the first organs to show degradtion as they were like filters? Just curious if that is a fact and does this indication then have more inferential scope significance than Opthomology?
330k traded at 946, looks like 200k and 500k blocks trying to get filled. I tried 50k shares and the spread was 20%, I'll wait for the sellers and hope for more entry. This may be our day of some recognition!